Subscribe to Newsletter
Business & Profession Basic & Translational Research

Also in the News…

From seaweed being used to create an artificial vitreous body replacement for retinal detachment, to the new drug combination developed to treat previously multidrug-resistant (MDR) strains of bacterial keratitis, these are the trailblazing studies that caught our attention this week…

Retinal seaweed. A new South Korean study has proposed an innovative method for treating retinal detachment. To replace the vitreous body of the eye, the team behind the study – which included ophthalmologists, chemical engineers, and pathologists – created an artificial hydrogel based on alginate, a viscous carbohydrate naturally occurring in seaweed. They concluded that the artificial substitute could serve as a possible vitreous replacement for real-world retinal detachment care. Link

Zika mechanisms. A new iScience study has identified several molecular mechanisms underlying the ocular abnormalities caused by the Zika virus, which include optic neuritis, hypoplasia of the optic nerve, and hemorrhagic retinopathy. The team aims to apply these mechanisms to identify potential targets for therapeutic intervention. Link

Critical flicker. The rate of visual perception in humans varies widely, according to new evidence found in a study conducted by Trinity College Dublin. To measure this visual perception speed (or “temporal resolution”), researchers used the critical flicker fusion threshold – a measure aimed at determining the maximum frequency someone can determine that a light source is flickering (as opposed to fusing into one constant light source). Link

Treating bacterial keratitis. In a recent Cornea study, researchers showed that a novel drug combination – polymyxin B/trimethoprim (PT) + rifampin – is effective in eliminating several pathogens associated with bacterial keratitis, eliminating all 43 of the isolates tested, including those isolates previously determined as MDR (multidrug-resistant). The authors are hopeful that further research might point to the combination as the potential gold standard treatment for bacterial keratitis. Link

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

About the Author
Alun Evans

Coming from a creative writing background, I have a great interest in fusing original, narrative-driven concepts with informative, educational content. Working at The Ophthalmologist allows me to connect with the great minds working in the field of contemporary eye care, and explore the human element involved in their scientific breakthroughs.

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Most Popular
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine



The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: